(NASDAQ: HURA) Tuhura Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 36.37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.39%.
Tuhura Biosciences's earnings in 2025 is -$31,673,814.On average, 6 Wall Street analysts forecast HURA's earnings for 2025 to be -$33,436,351, with the lowest HURA earnings forecast at -$33,351,271, and the highest HURA earnings forecast at -$33,106,042. On average, 6 Wall Street analysts forecast HURA's earnings for 2026 to be -$27,310,608, with the lowest HURA earnings forecast at -$31,879,892, and the highest HURA earnings forecast at -$14,188,304.
In 2027, HURA is forecast to generate -$18,207,072 in earnings, with the lowest earnings forecast at -$36,294,031 and the highest earnings forecast at $14,713,796.